Separator

IIFL AMC funds purchase an undisclosed stake in OmniActive Health Technologies

Separator
IIFL AMC funds purchase an undisclosed stake in OmniActive Health Technologies

CEO Insights Team, 0

OmniActive Health Technologies (‘OmniActive’ or ‘the Company’), which offers a wide range of premium, scientifically validated, natural nutraceutical ingredients, today announced that IIFL Asset Management Limited (‘IIFL AMC’), among the leaders in alternatives, has acquired a minority stake in the Company. Financial terms of the transaction were not disclosed. The investment has been made through IIFL AMCs Special Opportunities Fund series.

Established in 2005, OmniActive seeks to improve lives by enhancing nutrition and wellness through science and innovation. A leader in health solutions, the Company offers a range of premium natural ingredients that are innovative and scientifically validated for dietary supplementation and nutritional fortification. OmniActive works with leading human nutrition brands and manufacturers across the world to improve the health and well-being of consumers through a solution-oriented approach.The Company has R&Dand manufacturing operations in Pune, Hosur, Hassan and Thane in India;
and sales and distribution operations in the US, Europe, India, Asia, Australia and Latin America. TA Associates, a leading global private equity firm had acquired a significant stake in the Company in January 2021.

A leader in health solutions, the company offers a range of premium natural ingredients that are innovative and scientifically validated for dietary supplementation and nutritional fortification


Sanjaya Mariwala, Founder, MD and Executive Chairman, OmniActive, said “I am pleased to welcome IIFL Asset Management Limited as a shareholder in OmniActive and this transaction is a testament to the Company’s strong growth and reinforces the private equity fraternity’s continued belief in the growth of the nutraceutical sector”. Anshuman Goenka, Head Private Equity, IIFL Asset Management Limited, who led the transaction said, “We are delighted to partner with OmniActive in their vision to become a worldclass nutraceuticals player. We believe that this group is well poised to capture the increasing trend towards health conscious lifestyle and focus on natural health supplements. OmniActive has built a strong reputation and deep customer relationships with leading global brands and we are excited to partner with Mariwala, TA Associates and the OmniActive management team in the company’s growth story”. Investec acted as a sole sell side financial advisor to the transaction.